iBio announced its Q1 fiscal 2027 financial results with revenues rising to $1.1 million and increased R&D spending to advance its obesity drug candidates. The company presented promising preclinical data for IBIO-610, showing fat-selective weight loss when combined with GLP-1 therapy, and completed dosing in the Phase 1 trial of IBIO-600. iBio plans to file an IND-equivalent for IBIO-610 by the end of 2026 and start human trials in early 2027, while advancing IBIO-600 trials and other preclinical programs. These developments aim to improve obesity treatment and long-term health outcomes.
iBio's Q1 fiscal 2027 financial results and corporate update provide context for health sector trading activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 11, 2026 04:02 WIB: out of 150 priced health-sector US stocks, 52 rose and 97 fell. Notable movers include MRNA (Moderna, Inc.) at USD 251.19 with a 1-day change of -6.62% and Pluang order activity of 45% Sell / 55% Buy, RXRX (Recursion Pharmaceuticals Inc) at USD 3.56 down 6.44% with 0% Sell / 100% Buy, and NVAX (Novavax Inc) at USD 10.21 down 6.24% with 100% Sell / 0% Buy. Typical hold times vary from 23 to 60 days on Pluang.
Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...
Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...
TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...
Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...
OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...
